PHocus: a global Phase 2 study of inhaled mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD)Hossein Ardeschir Ghofrani, Marc Humbert, Laura Price et al.|Unknown|2025Cited by 0